Talent
Investor Portal
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Newsroom
latest news from ose
and across our portfolio
Featured News
August 31, 2023
Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
Article links to www.globenewswire.com
September 27, 2023
Sitryx raises additional $39 million to progress development of disease-modifying therapeutics
Article links to prn.to
October 3, 2023
The Oxford-Harrington Rare Disease Centre Launches
Article links to www.beacontx.com
June 12, 2023
Beacon Therapeutics launches with £96 million to develop a new generation of gene therapies for retinal diseases
Article links to innovation.ox.ac.uk
May 22, 2023
Oxford University retains No. 1 spot for spinouts
Article links to www.ultromics.com
April 26, 2023
Ultromics granted FDA Breakthrough Device Designation
Article links to www.caristo.com
April 17, 2023
Caristo Diagnostics Completes Series A Financing and Welcomes New CEO
Article links to quantummotion.tech
February 21, 2023
Quantum Motion Raises £42 Million Investment Round
All News
09•08•23
Portfolio News
Evox Therapeutics
Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics’s proprietary exosome engineering platform
04•08•23
Portfolio News
Evox Therapeutics
Evox Therapeutics enters into agreement to advance next generation exosome-delivered AAV gene therapy for the treatment of heart disease
20•06•23
Portfolio News
Evox Therapeutics
Evox Therapeutics Acquires Exosome AAV Technology and Intellectual Property
17•05•23
Portfolio News
Evox Therapeutics
Evox Therapeutics granted key US exosome purification patent
08•11•21
Portfolio News
Evox Therapeutics
Evox Therapeutics expands its exosome patent portfolio
21•10•21
Portfolio News
Evox Therapeutics
Landmark paper highlights Evox Therapeutics’ cutting edge exosome engineering approach for enhanced surface display of biologics
18•02•21
Portfolio News
Evox Therapeutics
Evox Therapeutics completes £69.2 million Series C financing
18•01•21
Portfolio News
Evox Therapeutics
John McHutchison joins the board of Evox Therapeutics
19•11•20
Portfolio News
Evox Therapeutics
Evox Therapeutics announces launch of strategic collaboration with the University of Oxford
Menu
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Talent
Investor Portal